Related Experiment Video
Updated: Jan 17, 2026

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection
Published on: February 10, 2017
Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world
Yongbo Yang1, Yan He1, Wan Wei1
1First Department of Thoracic Surgery, Peking University Cancer Hospital & Institute, Beijing, China.
Background:
While postoperative nutritional support for esophageal cancer is well-documented, the impact of nutritional intervention during neoadjuvant therapy remains understudied. This study investigates the role of nutritional support during neoadjuvant therapy in improving perioperative outcomes for esophageal cancer patients.
Methods:
A retrospective analysis of 454 esophagectomy patients following neoadjuvant therapy was conducted. Patients were categorized into a nutrition effective group (weight maintenance or gain, n=304) and a control group (weight loss, n=150) according to their weight change after nutritional intervention. Preoperative nutritional status, therapy completion, adverse reactions, postoperative pathological outcomes, and complications were compared between groups.
Results:
Compared to the control group, the nutrition effective group demonstrated (I) improved nutritional status during neoadjuvant therapy with higher body mass index (BMI) changes (0.85±0.88 vs. -0.90±0.65 kg/m2, P<0.001) and reduced Nutritional Risk Screening (NRS) scores (0.72±0.89 vs. 0.53±0.82, P=0.03); (II) higher neoadjuvant therapy completion rate (82.9% vs. 74.7%, P=0.04); (III) lower incidence of grade 3 or higher adverse reactions during neoadjuvant therapy (13.8% vs. 21.3%, P=0.04); and (IV) reduced postoperative anastomotic leakage rates (10.2% vs. 17.3%, P=0.03). No significant differences were observed in postoperative hospital stay, grade 3 or higher complications, or pathological response rates [tumor regression grade (TRG) ≤2, major pathological remission (mPR), and pathological complete remission (pCR)].
Conclusions:
Nasogastric tube feeding plays a pivotal role in effective nutritional support during neoadjuvant therapy. Effective nutritional intervention not only improves preoperative nutritional status and enhances neoadjuvant therapy completion but also mitigates grade 3 or higher adverse events and reduces the incidence of anastomotic leakage. Additionally, it may potentially contribute to improved postoperative pathological remission.
More Related Videos
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

